MX394245B - Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia. - Google Patents

Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia.

Info

Publication number
MX394245B
MX394245B MX2018014080A MX2018014080A MX394245B MX 394245 B MX394245 B MX 394245B MX 2018014080 A MX2018014080 A MX 2018014080A MX 2018014080 A MX2018014080 A MX 2018014080A MX 394245 B MX394245 B MX 394245B
Authority
MX
Mexico
Prior art keywords
fibromyalgia
syndrome associated
carbamate compound
prevent
treat
Prior art date
Application number
MX2018014080A
Other languages
English (en)
Other versions
MX2018014080A (es
Inventor
Han Ju Yi
Min Jae Jo
Sun Gwan Hwang
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Publication of MX2018014080A publication Critical patent/MX2018014080A/es
Publication of MX394245B publication Critical patent/MX394245B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La presente invención se relaciona a una composición farmacéutica para prevenir o tratar fibromialgia o un síndrome funcional asociado con fibromialgia, la composición farmacéutica que comprende: un compuesto de carbamato de la fórmula química 1 o una sal, un solvato o un hidrato farmacéuticamente aceptable del mismo; y un portador farmacéuticamente aceptable. La composición farmacéutica, de acuerdo con la presente invención, puede permitir el tratamiento eficiente de fibromialgia o un síndrome funcional asociado con fibromialgia.
MX2018014080A 2016-05-19 2017-05-18 Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia. MX394245B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160061392 2016-05-19
PCT/KR2017/005173 WO2017200318A1 (ko) 2016-05-19 2017-05-18 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Publications (2)

Publication Number Publication Date
MX2018014080A MX2018014080A (es) 2019-04-04
MX394245B true MX394245B (es) 2025-03-19

Family

ID=60325216

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018014080A MX394245B (es) 2016-05-19 2017-05-18 Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia.

Country Status (14)

Country Link
US (1) US10849882B2 (es)
EP (1) EP3459543B1 (es)
JP (1) JP7071287B2 (es)
KR (1) KR102489052B1 (es)
CN (1) CN109475529B (es)
AU (1) AU2017265839B2 (es)
BR (1) BR112018073553A2 (es)
CA (1) CA3024286A1 (es)
DK (1) DK3459543T3 (es)
ES (1) ES2935596T3 (es)
MX (1) MX394245B (es)
PL (1) PL3459543T3 (es)
RU (1) RU2753525C2 (es)
WO (1) WO2017200318A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7086076B2 (ja) * 2016-12-14 2022-06-17 エスケー バイオファーマスティカルズ カンパニー リミテッド 振戦又は振戦症候群の予防、軽減又は治療のためのカルバメート化合物の使用
US11666554B2 (en) * 2017-11-14 2023-06-06 Sk Biopharmaceuticals Co., Ltd. Use of a carbamate compound to prevent, alleviate or treat visceralgia or pain arising from visceral disease
US11406620B2 (en) * 2017-11-14 2022-08-09 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current
JP7258901B2 (ja) 2017-11-14 2023-04-17 エスケー バイオファーマスティカルズ カンパニー リミテッド 欠神発作又は欠神発作を示すてんかんの予防、軽減又は治療のためのカルバメート化合物の使用
TWI837197B (zh) * 2018-10-19 2024-04-01 南韓商愛思開生物製藥股份有限公司 胺基甲酸酯化合物於預防、緩解或治療糖尿病周邊神經病變或化療誘發的周邊神經病變的用途
KR20220104746A (ko) * 2019-11-22 2022-07-26 에스케이바이오팜 주식회사 카바메이트 화합물을 포함하는 경구용 약제학적 조성물 및 그 제조방법
IT202300007314A1 (it) 2023-04-14 2024-10-14 Soal Pharma Srl Integratore alimentare per il trattamento della fibromialgia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
CN101669933A (zh) * 2001-07-16 2010-03-17 奥索-麦克尼尔药品公司 用于预防或治疗神经性疼痛和丛集性头痛及偏头痛性疼痛的氨基甲酸酯化合物
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
WO2010150946A1 (en) * 2009-06-22 2010-12-29 Sk Holdings Co., Ltd. Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester
US8404461B2 (en) * 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
KR101783633B1 (ko) * 2009-11-06 2017-10-10 에스케이바이오팜 주식회사 섬유근육통 증후군의 치료 방법

Also Published As

Publication number Publication date
PL3459543T3 (pl) 2023-04-11
RU2753525C2 (ru) 2021-08-17
ES2935596T3 (es) 2023-03-08
RU2018144785A3 (es) 2020-08-11
DK3459543T3 (da) 2023-02-13
BR112018073553A2 (pt) 2019-03-19
EP3459543B1 (en) 2022-12-21
US20190298694A1 (en) 2019-10-03
KR20170131242A (ko) 2017-11-29
CN109475529B (zh) 2022-02-22
RU2018144785A (ru) 2020-06-19
KR102489052B1 (ko) 2023-01-16
CN109475529A (zh) 2019-03-15
CA3024286A1 (en) 2017-11-23
AU2017265839B2 (en) 2022-10-27
AU2017265839A1 (en) 2018-12-13
JP7071287B2 (ja) 2022-05-18
JP2019516707A (ja) 2019-06-20
EP3459543A4 (en) 2020-01-15
MX2018014080A (es) 2019-04-04
WO2017200318A1 (ko) 2017-11-23
EP3459543A1 (en) 2019-03-27
US10849882B2 (en) 2020-12-01

Similar Documents

Publication Publication Date Title
MX394245B (es) Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia.
ZA202202097B (en) Amino pyrimidine ssao inhibitors
CY1124652T1 (el) Παραγωγα 1η-ινδαζολο-3-καρβοξαμιδιου και σχετικες ενωσεις ως αναστολεις παραγοντα d για τη θεραπεια νοσων που χαρακτηριζονται απο μη φυσιολογικη δραστηριοτητα συστηματος συμπληρωματος, οπως π.χ. ανοσολογικες διαταραχες
SA518400356B1 (ar) مثبطات الأرجيناز واستخداماتها العلاجية
MY199409A (en) N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors
BR112018070602A2 (pt) composto, composição farmacêutica, uso do composto, e, método para tratar uma doença ou distúrbio
MX2021006011A (es) Un inhibidor de la quinasa aurora a para su uso en el tratamiento del neuroblastoma.
BR112017003054A2 (pt) compostos de aminopirimidinila como inibidores de jak
MX384905B (es) Degradadores de proteínas de bromodominio y dominioextraterminal (bet).
MX395482B (es) Compuestos antiproliferativos y metodos de uso de los mismos
EA201891203A1 (ru) Гетероциклические соединения в качестве иммуномодуляторов
UA118149C2 (uk) Інгібітор jak
EA201792116A1 (ru) Ингибитор янус-киназы
EA201990044A1 (ru) Гетероциклические соединения в качестве антибактериальных средств
MX2019009501A (es) Compuestos de amino piridina utiles como inhibidores de ssao.
PH12019501690A1 (en) Pyrimidine compound and pharmaceutical use thereof
MX2020003593A (es) Compuestos de benzotiazol y metodos para usar los mismos para tratar trastornos neurodegenerativos.
HK1254954A1 (zh) Lpt-723和免疫检查点抑制剂组合物及其治疗方法
MX388175B (es) Compuestos terapéuticos y métodos para utilizarlos
JOP20190053A1 (ar) مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط
EA035519B9 (ru) 1,3,4-тиадиазольные соединения и их применение в лечении рака
MX2021012096A (es) Compuestos de indenilo, composiciones farmaceuticas y usos medicos del mismo.
DOP2018000134A (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cáncer
EA201991688A1 (ru) Фармацевтические комбинации для лечения рака
MX2022006229A (es) Composiciones y metodos para el tratamiento de resistencia a la insulina.